Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Celebrating Progress and Anticipating Success in 2024
As 2023 comes to a close, we extend our appreciation to each of you for following our monthly NASH News updates, supporting GLI’s work, and your steadfast dedication to advancing liver health. While we celebrate this year’s accomplishments, there’s more work ahead, and we eagerly anticipate another successful year in 2024.
GLI Celebrates Dr. Monica Bertagnolli’s Senate Confirmation as Director of NIH
Global Liver Institute is proud to have been an early supporter of the President’s nominee, Dr. Monica Bertagnolli, as the Director of the National Institutes of Health (NIH). After nearly 2 years since Dr. Francis Collins left the position, the Senate on a bipartisan vote has now confirmed Dr. Bertagnolli as the new NIH Director.
New App Helps Predict Pediatric Transplant Need
Physicians from the Children’s Hospital Los Angeles have created a web-based app to predict whether children in acute liver failure will need a liver transplant.
Congress continues struggle to advance funding bills, agencies continue their work.
Congress narrowly averted a government shutdown in October and has made little progress on advancing appropriations bills needed to continue funding the government through Fiscal Year 2024.
Alarming Trends in Fatty Liver Disease (Especially in Children) Shortening Life Spans
Global Fatty Liver Day, formerly known as International NASH Day, is a public education campaign that was inaugurated in June 2018 to enhance awareness and emphasize the pressing nature of fatty liver disease, particularly its advanced stages.
The Positive Future of Liver Cancer Research
Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world.
Liver Health at Forefront of Legislative and Regulatory Activity
Congress returned in September to advance appropriations bills and debate key legislative priorities, while the administration worked on policies impacting liver health by addressing disability protections in organ transplantation and with regard to the Cancer Moonshot.
Building on Fatty Liver Awareness and Treatments
As prospects for new fatty liver and NASH treatments appear on the horizon, GLI continues to push for better awareness, screening, and treatment options. With fatty liver disease being diagnosed in a growing pediatric population, understanding the role of nutrition, risks, and the connection to co-occurring disorders is vital to addressing this chronic, progressive disease.
Updated Patient Registry, Drug Development Progress, & More!
This month, significant strides have been made in addressing rare liver disease care. Updates to patient registries, novel therapeutic options, and strategies for expediting prior authorizations in rare diseases are highlighted below.
Recognizing Liver Cancer Awareness Month!
Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world.
Global Communities Rally around Third Deadliest Cancer – Liver Cancer
(Washington, D.C., October 1, 2023) – Today marks the start of Liver Cancer Awareness Month, which will feature the monthlong #OctoberIs4Livers multifaceted campaign led by Global Liver Institute (GLI) to promote awareness of the disease, mark progress made, and identify key areas of global focus to make improvements for liver cancer patients. In addition to a comprehensive social media campaign, “Liver Cancer Lessons” education series, and featured conversations with expert guests and GLI CEO Donna R. Cryer, JD, partners around the world will host Open House events to inform and advocate to fight liver disease in their communities.
The Latest at GLI: Reasons for Celebration! 🎊
As we turn the corner into the fall 🍂 (or spring🌸, for our southern hemisphere friends), there is much to celebrate and much to accomplish in the last few months of the year.